Eternity Healthcare To Develop A Noninvasive Saliva-Based Sugar Monitor Device To Test For Diabetes

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHOENIX and VANCOUVER, British Columbia, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Eternity Healthcare Inc. (OTCBB:ETAH), a leading medical device and diagnostic company with special focus on diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood.

Help employers find you! Check out all the jobs and post your resume.